Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Financial Information > SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
8-K current report May 25, 2016 105.0 KB View HTML View PDF Add to Briefcase
10-Q quarterly report May 6, 2016 421.5 KB View HTML View PDF View XLS View XBRL Add to Briefcase
8-K current report May 5, 2016 255.2 KB View HTML View PDF View XLS Add to Briefcase
DEF 14A definitive proxy statement Apr 29, 2016 1.4 MB View HTML View PDF View XLS Add to Briefcase
D small company offering and sale of securities without registration Apr 28, 2016 110.3 KB View HTML View PDF Add to Briefcase
4 turgeon, joseph w. Apr 19, 2016 152.4 KB View HTML View PDF View XLS Add to Briefcase
4 gustafson, kurt a Mar 25, 2016 152.5 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Mar 24, 2016 104.0 KB View HTML View PDF Add to Briefcase
4 shrotriya, rajesh c MD Mar 24, 2016 157.5 KB View HTML View PDF View XLS Add to Briefcase
4 turgeon, joseph w. Mar 24, 2016 152.1 KB View HTML View PDF View XLS Add to Briefcase
4 gustafson, kurt a Mar 24, 2016 153.9 KB View HTML View PDF View XLS Add to Briefcase
10-K annual report Mar 14, 2016 1.5 MB View HTML View PDF View XLS View XBRL Add to Briefcase
4 spectrum, pharmaceuticals inc Mar 11, 2016 155.3 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Mar 11, 2016 145.1 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Mar 9, 2016 280.8 KB View HTML View PDF View XLS Add to Briefcase
4 gustafson, kurt a Feb 22, 2016 152.7 KB View HTML View PDF View XLS Add to Briefcase
4 turgeon, joseph w. Feb 22, 2016 152.2 KB View HTML View PDF View XLS Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 22, 2016 101.9 KB View HTML View PDF View XLS Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2016 145.7 KB View HTML View PDF View XLS Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 11, 2016 100.4 KB View HTML View PDF View XLS Add to Briefcase
Showing 1-20 of 1139 Page: 1 2 3 4 5 ... 57  Next 20
Add to Briefcase = add PDF file to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
7.53
Change:
+ 0.16
Day High:
7.67
Day Low:
7.38
Volume:
814,653
4:00 PM ET on May 25, 2016
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR